Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma
The HemOnc Pulse
00:00
PD One Inhibitor
In terms of sort of new agents, so we saw some data on a lag three inhibitors. In combination with Pembrolyism map, this within sort of multiple relapse, Hodgkin lymphoma. And to be honest, it's difficult to know quite what to make of the data.
Transcript
Play full episode
